BOSTON, Mass--Under a grant from the US Army Breast Cancer Program,
Harvard researchers are attempting to create medullary carcinoma
of the breast (MCB) cell lines as part of their immunologic studies.
There is currently only one line in the world for this infrequent
tumor. "We are especially interested in pleural effusions
(or ascites)--the best source to make cell lines--but will also
use fresh, unfixed tumor tissue, and will pay all shipping costs,"
said investigator Richard Junghans, PhD, MD.
Departments are asked to post the request, which remains in effect
until January 1, 1998. Prior to thoracentesis, or, when possible,
tumor excision, please call Dr. Junghans or Dr. P. Telleman at
617-632-0943; fax: 617-632-0998. (The MCB cell line is from the
Armed Forces Institute of Pathology, Atlas #67-1-42.)